21
Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
Condition(s):HIV Infections; Dyslipidemia; Endothelial DysfunctionLast Updated:December 18, 2012Completed
Niacin: 623 Clinical Trials, Page 3 of 63
Hide Studies Not Open or Pending
22
Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America
Condition(s):Cardiovascular DiseasesLast Updated:June 6, 2014Completed
23
Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome
Condition(s):Cancer; Skin Fibroblasts; Muscle WeaknessLast Updated:December 8, 2020Completed
24
Study of Nicotinamide in Early Onset Preeclampsia
Condition(s):PreeclampsiaLast Updated:September 13, 2021Completed
25
“Pharmacokinetic Study of Nicotinamide Riboside”
Condition(s):Metabolic DisturbanceLast Updated:February 8, 2018Completed
26
Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
Condition(s):Central Retinal Vein Occlusion; Branch Retinal Vein OcclusionLast Updated:November 13, 2019Terminated
27
Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions
Condition(s):HealthyLast Updated:August 22, 2013Completed
28
Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition(s):Polycystic Kidney DiseaseLast Updated:February 11, 2019Completed
29
SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
Condition(s):DyslipidemiaLast Updated:August 21, 2008Completed
30
Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)
Condition(s):DyslipidemiaLast Updated:April 9, 2015Withdrawn